The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C.
Jia-Jung LeeYu-Ju WeiMing-Yen LinSheng-Wen NiuPo-Yao HsuJiun-Chi HuangTyng-Yuang JangMing-Lun YehChing-I HuangPo-Cheng LiangYi-Hung LinMing-Yen HsiehMeng-Hsuan HsiehSzu-Chia ChenChia-Yen DaiZu-Yau LinShinn-Cherng ChenJee-Fu HuangJer-Ming ChangShang-Jyh HwangChung-Feng HuangYi-Wen ChiuWan-Long ChuangMing-Lung YuPublished in: PloS one (2020)
This study confirmed the traditional category level of APRI and FIB-4 were unable to identify liver fibrosis of CHC hemodialysis patients. With the adjusted cut-off value, APRI and FIB-4 still showed suboptimal diagnostic accuracy. Our results suggest the necessary of TE measures for liver fibrosis in the CHC uremic population.